1450亿元“砍骨”自救,强生果断断臂“整容”

华夏时报网
Feb 28

强生曾经凭借“买买买”登上全球骨科之巅,如今却急于将曾经的基石业务“卖卖卖”。  近日,据知情人士透露,医疗健康巨头JNJ" target="_blank" web="1">强生公司(Johnson & Johnson, JNJ.N)正在重新评估其骨科业务DePuy Synthes的剥离方案,考虑以超过200亿美元(折合人民币约1450亿元)的价格直接出售该部门,而非此前计划的分拆上市。  ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10